The role of metabolic syndrome in the development of polycystic ovary syndrome in adolescence




obesity, metabolic syndrome, polycystic ovary syndrome, adolescence, diagnosis, treatment, prevention


The review article presents an analysis of the metabolic syndrome problem in children and adolescents, its role in the development of polycystic ovary syndrome (PCOS) in accordance with the latest International guidelines and modern literature. The urgency of the problem lies in the rapid spread of overweight among children in the world and, consequently, the growth of alimentary-dependent pathology. One of the major consequences of weight problems is metabolic syndrome (MS).

There are still no clear MS criteria for children and adolescents. IDF suggests using IDF criteria for adults. Priority in the pathogenesis of MS is given to insulin resistance (IR), which is associated with puberty. The problem of IR assessment remains. HOMA-IR and QUICKI methods are not considered reliable tests to determine IR, so the assessment is based on clinical signs (hyperglycemia, dyslipidemia, abdominal obesity, hypertension).

Obesity and IR can be predictors of PCOS, which can often be associated with puberty. Pathological signs of the syndrome typical for adults in adolescence may be a manifestation of the physiological course of puberty. Obligative criteria for the diagnosis of PCOS in adolescence are irregular menstruation/oligomenorrhea, proven biochemically and clinically hyperandrogenemia).

First-line therapy for PCOS in adolescents with MS is weight loss and dosed exercise, which helps to normalize a hormonal balance. Drug treatment may include insulin-sensitizing drugs (metformin), antiandrogens (spironlactone, flutamide, cyproterone acetate), 5-alpha-reductase inhibitors (finasteride), combined oral contraceptives, inositol. Prevention of overweight, obesity in children can prevent the development of IR and, accordingly, associated MS and PCOS, reproductive health disorders. Prevention measures are aimed at avoiding maternal obesity, gestational diabetes, malnutrition and smoking during pregnancy, promoting breastfeeding and physical activity.

Author Biographies

N. V. Avramenko, Zaporizhzhia State Medical and Pharmaceutical University, Ukraine

Professor, Head of the Department of Obstetrics, Gynecology and Reproductive Medicine, Faculty of Postgraduate Education

O. V. Kabachenko, Zaporizhzhia State Medical and Pharmaceutical University, Ukraine

MD, PhD, Assistant of the Department of Obstetrics, Gynecology and Reproductive Medicine, Faculty of Postgraduate Education

D. Ye. Barkovskyi, Zaporizhzhia State Medical and Pharmaceutical University, Ukraine

MD, PhD, DSc, Professor of the Department of Obstetrics, Gynecology and Reproductive Medicine, Faculty of Postgraduate Education

К. V. Sierykh, Zaporizhzhia State Medical and Pharmaceutical University, Ukraine

MD, Senior Laboratory Assistant of the Department of Obstetrics, Gynecology and Reproductive Medicine


Antypkin, Yu. H., Horban, N. Ye., & Lutsenko, O. H. (2021). Faktory ryzyku rozvytku khvorob tsyvilizatsii [Risk factors for the development of civilization diseases]. Zdorovia Ukrainy. (Akusherstvo Hinekolohia Reproduktolohiia), (1), 8-12. [in Ukrainian].

Zhuk, S. I., & Gordiychuk, A B. (2018). SPKYa: fenotipy, vistseralnoe ozhirenie i personalizirovannyi podkhod v naznachenii KOK [PCOS: phenotypes, visceral obesity and a personalized approach in the prescription of COC]. Reproductive Endocrinology, (2), 34-41. [in Russian].

GBD 2015 Obesity Collaborators, Afshin, A., Forouzanfar, M. H., Reitsma, M. B., Sur, P., Estep, K., Lee, A., Marczak, L., Mokdad, A. H., Moradi-Lakeh, M., Naghavi, M., Salama, J. S., Vos, T., Abate, K. H., Abbafati, C., Ahmed, M. B., Al-Aly, Z., Alkerwi, A., Al-Raddadi, R., Amare, A. T., … Murray, C. J. L. (2017). Health Effects of Overweight and Obesity in 195 Countries over 25 Years. The New England journal of medicine, 377(1), 13-27.

Syusyuka, V. G., Sergienko, M. Y., Makurina, G. I., Yershova, O. A., & Chornenka, A. S. (2021). Syndrom polikistoznykh yaiechnykiv: kliniko-patohenetychni aspekty multydystsyplinarnoi problemy [Polycystic ovary syndrome:clinical and pathogenetic aspects of a multidisciplinary problem]. Reproductive Health of Woman, (2), 7-14. [in Ukrainian].

Song, M., & Giovannucci, E. (2018). Substitution analysis in nutritional epidemiology: proceed with caution. European journal of epidemiology, 33(2), 137-140.

Semeniuk, L. M., Yuzvenko, T. Yu., & Larina, O. V. (2018). Osoblyvosti vuhlevodnoho obminu u zhinok rannoho reproduktyvnoho viku iz skleropolikistozom yaiechnykiv [Features of carbohydrate metabolism in women of early reproductive age with polycystic ovary syndrome]. Mizhnarodnyi endokrynolohichnyi zhurnal, 14(3), 236-241. [in Ukrainian].

DeBoer, M. D., Filipp, S. L., & Gurka, M. J. (2019). Geographical variation in the prevalence of obesity and metabolic syndrome among US adolescents. Pediatric obesity, 14(4), e12483.

Shmyhol, I. V., & Dubenets, D. S. (2021). Poshyrenist nadmirnoi vahy ta ozhyrinnia sered shkoliariv silskoi mistsevosti [Prevalence of overweight and obesity among rural schoolchildren]. Zbirnyk naukovykh prats ΛΌHOΣ (Vol. 1), (pp. 137-139). [in Ukrainian].

DeBoer, M. D. (2019). Assessing and Managing the Metabolic Syndrome in Children and Adolescents. Nutrients, 11(8), 1788.

O'Connor, E. A., Evans, C. V., Burda, B. U., Walsh, E. S., Eder, M., & Lozano, P. (2017). Screening for Obesity and Intervention for Weight Management in Children and Adolescents: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA, 317(23), 2427-2444.

Sergiyenko, M. Yu., Siusiuka, V. G., Makurina, G. I., Deinichenko, O. V. Kolokot, N. G., & Chornenka, A. S. (2022). Modern approaches to the diagnosis and treatment of polycystic ovary syndrome in adolescence. Reproductive Health of Woman, (2), 73-78.

Peña, A. S., Witchel, S. F., Hoeger, K. M., Oberfield, S. E., Vogiatzi, M. G., Misso, M., Garad, R., Dabadghao, P., & Teede, H. (2020). Adolescent polycystic ovary syndrome according to the international evidence-based guideline. BMC medicine, 18(1), 72.

Teede, H., Misso, M., Costello, M., Dokras, A., Laven, J., Moran, L., Piltonen T., & Norman, R. (2018). International evidence-based guideline for the assessment and management of polycystic ovary syndrome 2018. National Health and Medical Research Council (NHMRC) (pp. 1-198).

Ibáñez, L., Oberfield, S. E., Witchel, S., Auchus, R. J., Chang, R. J., Codner, E., Dabadghao, P., Darendeliler, F., Elbarbary, N. S., Gambineri, A., Garcia Rudaz, C., Hoeger, K. M., López-Bermejo, A., Ong, K., Peña, A. S., Reinehr, T., Santoro, N., Tena-Sempere, M., Tao, R., Yildiz, B. O., … Lee, P. A. (2017). An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence. Hormone research in paediatrics, 88(6), 371-395.

Fornari, E., & Maffeis, C. (2019). Treatment of Metabolic Syndrome in Children. Frontiers in endocrinology, 10, 702.

Gurka, M. J., Golden, S. H., Musani, S. K., Sims, M., Vishnu, A., Guo, Y., Cardel, M., Pearson, T. A., & DeBoer, M. D. (2017). Independent associations between a metabolic syndrome severity score and future diabetes by sex and race: the Atherosclerosis Risk In Communities Study and Jackson Heart Study. Diabetologia, 60(7), 1261-1270.

DeBoer, M. D., Filipp, S. L., Sims, M., Musani, S. K., & Gurka, M. J. (2020). Risk of Ischemic Stroke Increases Over the Spectrum of Metabolic Syndrome Severity. Stroke, 51(8), 2548-2552.

DeBoer, M. D., Filipp, S. L., Musani, S. K., Sims, M., Okusa, M. D., & Gurka, M. (2018). Metabolic Syndrome Severity and Risk of CKD and Worsened GFR: The Jackson Heart Study. Kidney & blood pressure research, 43(2), 555-567.

Leong, K. S. W., Jayasinghe, T. N., Wilson, B. C., Derraik, J. G. B., Albert, B. B., Chiavaroli, V., Svirskis, D. M., Beck, K. L., Conlon, C. A., Jiang, Y., Schierding, W., Vatanen, T., Holland, D. J., O'Sullivan, J. M., & Cutfield, W. S. (2020). High prevalence of undiagnosed comorbidities among adolescents with obesity. Scientific reports, 10(1), 20101.

Kaminskyi, V. V., Tatarchuk, T. F., & Dubossarska, Y. O. (2016). Natsionalnyi konsensus shchodo vedennia patsiientok iz hiperandroheniieiu [National consensus on the management of patients with hyperandrogenism (2016)]. Reproductive Endocrinology, (4), 19-31. [in Ukrainian].

Avramenko N. V., Kabachenko O. V., Barkovskyi D. Ye., & Sierykh K. V. (2020). Suchasni aspekty menedzhmentu patsiientok iz syndromom polikistozu yaiechnykiv [Modern aspects of management of patients with polycystic ovary syndrome]. Zaporozhye medical journal, 22(6). 865-873. [in Ukrainian].

Cheng, T. S., Day, F. R., Lakshman, R., & Ong, K. K. (2020). Association of puberty timing with type 2 diabetes: A systematic review and meta-analysis. PLoS medicine, 17(1), e1003017.

Kakoly, N. S., Khomami, M. B., Joham, A. E., Cooray, S. D., Misso, M. L., Norman, R. J., Harrison, C. L., Ranasinha, S., Teede, H. J., & Moran, L. J. (2018). Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression. Human reproduction update, 24(4), 455-467.

Caroppo, F., Galderisi, A., Ventura, L., & Belloni Fortina, A. (2021). Metabolic syndrome and insulin resistance in pre-pubertal children with psoriasis. European journal of pediatrics, 180(6), 1739-1745.

Tagi, V. M., Giannini, C., & Chiarelli, F. (2019). Insulin Resistance in Children. Frontiers in endocrinology, 10, 342.

Cassar, S., Misso, M. L., Hopkins, W. G., Shaw, C. S., Teede, H. J., & Stepto, N. K. (2016). Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies. Human reproduction, 31(11), 2619-2631.

Tatarchuk, T. F. (2021). Yak podolaty insulinorezystentnist pry syndromi polikistoznykh yayechnykiv? [How to overcome insulin resistance in polycystic ovary syndrome?]. Zdorovia Ukrainy. (Akusherstvo Hinekolohia Reproduktolohiia), (1), 3-4. [in Ukrainian].

Spartano, N. L., Stevenson, M. D., Xanthakis, V., Larson, M. G., Andersson, C., Murabito, J. M., & Vasan, R. S. (2017). Associations of objective physical activity with insulin sensitivity and circulating adipokine profile: the Framingham Heart Study. Clinical obesity, 7(2), 59-69.

Kim, Y., & Je, Y. (2019). Early Menarche and Risk of Metabolic Syndrome: A Systematic Review and Meta-Analysis. Journal of women's health (2002), 28(1), 77-86.

Moslehi, N., Asghari, G., Mirmiran, P., & Azizi, F. (2021). Longitudinal association of dietary sources of animal and plant protein throughout childhood with menarche. BMC pediatrics, 21(1), 206.

Šaffa, G., Kubicka, A. M., Hromada, M., & Kramer, K. L. (2019). Is the timing of menarche correlated with mortality and fertility rates?. PloS one, 14(4), e0215462.

Farahmand, M., Tehrani, F. R., Dovom, M. R., & Azizi, F. (2017). Menarcheal Age and Risk of Type 2 Diabetes: A Community-Based Cohort Study. Journal of clinical research in pediatric endocrinology, 9(2), 156-162.

Peña, A. S., Doherty, D. A., Atkinson, H. C., Hickey, M., Norman, R. J., & Hart, R. (2018). The majority of irregular menstrual cycles in adolescence are ovulatory: results of a prospective study. Archives of disease in childhood, 103(3), 235-239.

Kim, J. Y., Tfayli, H., Michaliszyn, S. F., Lee, S., Nasr, A., & Arslanian, S. (2017). Anti-Müllerian Hormone in Obese Adolescent Girls With Polycystic Ovary Syndrome. The Journal of adolescent health, 60(3), 333-339.

Morley, L. C., Tang, T., Yasmin, E., Norman, R. J., & Balen, A. H. (2017). Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. The Cochrane database of systematic reviews, 11(11), CD003053.

Uysal, G., Sahin, Y., Unluhizarci, K., Ferahbas, A., Uludag, S. Z., Aygen, E., & Kelestimur, F. (2017). Is acne a sign of androgen excess disorder or not? European Journal of Obstetrics & Gynecology, and Reproductive Biology, 211, 21-25.

Scheitel, M. R., Kessler, M. E., Shellum, J. L., Peters, S. G., Milliner, D. S., Liu, H., Komandur Elayavilli, R., Poterack, K. A., Miksch, T. A., Boysen, J., Hankey, R. A., & Chaudhry, R. (2017). Effect of a Novel Clinical Decision Support Tool on the Efficiency and Accuracy of Treatment Recommendations for Cholesterol Management. Applied clinical informatics, 8(1), 124-136.

Tatarchuk, T. F., & Kaluhina, L. V. (2018). Perspektyvy vykorystannia inozytoliv u korektsii insulinorezystentnosti u zhinok iz syndromom polikistoznykh yaiechnykiv [Prospects for the use of inositols in the correction of insulin resistance in women with polycystic ovary syndrome]. Zdorovia Ukrainy. (Hinekolohiia, Akusherstvo, Reproduktolohiia), (1), 5-6. [in Ukrainian].

Soliman, A., De Sanctis, V., Alaaraj, N., & Hamed, N. (2020). The clinical application of metformin in children and adolescents: A short update. Acta bio-medica : Atenei Parmensis, 91(3), e2020086.

Faculty of Sexual & Reproductive Healthcare. (2020). FSRH Clinical Guideline: Combined Hormonal Contraception (January 2019, Amended November 2020).

Kalugina, L. V., & Yusko, T. I. (2018). Mio-inozitol: terapevticheskie vozmozhnosti i pregravidarnaya podgotovka pri sindrome polikistoznykh yaichnikov. Obzor literatury [Myo-inositol: therapeutic possibilities and pregravid preparation in women with pcos]. Reproductive Endocrinology, (4), 40-45. [in Russian].

Lang, A. Y., Boyle, J. A., Fitzgerald, G. L., Teede, H., Mazza, D., Moran, L. J., & Harrison, C. (2018). Optimizing preconception health in women of reproductive age. Minerva ginecologica, 70(1), 99-119.



How to Cite

Avramenko NV, Kabachenko OV, Barkovskyi DY, Sierykh КV. The role of metabolic syndrome in the development of polycystic ovary syndrome in adolescence. Zaporozhye Medical Journal [Internet]. 2023May31 [cited 2024Jun.18];25(3):255-61. Available from: